EUVIMEDEUVIMED entdecken
Systematische ÜbersichtVergleichsstudieOpen Access · CC BY 4.0

A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma – A systematic review

Xiaomin Huang, Paul Leo, Lee Jones, Pascal H G Duijf, Gunter Hartel, Lizbeth Kenny, Sarju Vasani, Chamindie Punyadeera

Mutation Research - Reviews in Mutation Research · 2024

DOI: 10.1016/j.mrrev.2023.108477 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Mutation Research - Reviews in Mutation Research, 2024. Verfasst von Xiaomin Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Saliva and Liquid Biopsy Translational Laboratory, Griffith Institute for Drug Discovery, The School of Environment and Science, Griffith University,…. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mutation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Head and neck cancer is the seventh most common malignancy globally. Head and neck squamous cell carcinoma (HNSCC) originates from squamous cells and 90% of HNC are HNSCC. The gold standard for diagnosing HNSCC is tissue biopsy. However, given tumour heterogeneity, biopsies may miss important cancer-associated molecular signatures, and more importantly, after the tumour is excised, there is no means of tracking response to treatment in patients. Captured under liquid biopsy, circulating tumour DNA (ctDNA), may identify in vivo molecular genotypes and complements tumour tissue analysis in cancer management. A systematic search was conducted in PubMed, Embase, Scopus and the Cochran Library between 2012 to early 2023 on ctDNA in HNSCC using publications written in English. We summarise 20 studies that compared mutational profiles between tumour tissue DNA (tDNA) and ctDNA, using a cohort of 631 HNSCC patients and 139 controls. Among these studies, the concordance rates varied greatly and the most mutated and the most concordant gene was TP53, followed by PIK3CA, CDKN2A, NOTCH1 and FAT1. Concordant variants were mainly found in Stage IV tumours, and the mutation type is mostly single nucleotide variants (SNV). We conclude that, as a biomarker for HNSCC, ctDNA demonstrates great promise as it recapitulates tumour genotypes, however additional multi-central trials are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNASquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsMutationHumansClass I Phosphatidylinositol 3-KinasesBiomarkers, TumorTumor Suppressor Protein p53Receptor, Notch1DNA, NeoplasmCyclin-Dependent Kinase Inhibitor p16Cadherins

Stichwörter der Autor:innen

Circulating tumour DNAConcordanceHead and neck squamous cell carcinoma (HNSCC)MutationTumour DNA

Substanzen

Circulating Tumor DNAPIK3CA protein, humanClass I Phosphatidylinositol 3-KinasesBiomarkers, TumorTumor Suppressor Protein p53TP53 protein, humanFAT1 protein, humanCDKN2A protein, humanReceptor, Notch1NOTCH1 protein, human

Autor:innen und Institutionen

  • Saliva and Liquid Biopsy Translational Laboratory, Griffith Institute for Drug Discovery, The School of Environment and Science, Griffith University, Brisbane, QLD, Australia.
  • School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia; Center for Genomics and Personalised Health, Queensland University of Technology, Brisbane, QLD, Australia;…
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; Research Methods Group, School of Public Health and Social Work, Queensland University of Technology, Kelvin Grove, Brisbane, QLD, Australia.
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • School of Medicine, University of Queensland, Brisbane, QLD, Australia; Cancer Care Service, Royal Brisbane Women's Hospital, Brisbane, QLD, Australia.
  • Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Otolaryngology, Royal Brisbane Women's Hospital, Brisbane, QLD, Australia.

Zitieren

APA

Huang, X., Leo, P., Jones, L., Duijf, P. H. G., Hartel, G., Kenny, L., Vasani, S., & Punyadeera, C. (2024). A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma – A systematic review. Mutation Research - Reviews in Mutation Research. https://doi.org/10.1016/j.mrrev.2023.108477

Vancouver

Huang X, Leo P, Jones L, Duijf PHG, Hartel G, Kenny L, et al. A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma – A systematic review. Mutation Research - Reviews in Mutation Research. 2024. doi:10.1016/j.mrrev.2023.108477

BibTeX
@article{Huang2024,
  author = {Huang, Xiaomin and Leo, Paul and Jones, Lee and Duijf, Pascal H G and Hartel, Gunter and Kenny, Lizbeth and Vasani, Sarju and Punyadeera, Chamindie},
  title = {A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma – A systematic review},
  journal = {Mutation Research - Reviews in Mutation Research},
  year = {2024},
  doi = {10.1016/j.mrrev.2023.108477}
}
Kostenlos starten →